{"id":475435,"date":"2020-03-23T06:04:01","date_gmt":"2020-03-23T06:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=475435"},"modified":"2020-03-23T06:04:01","modified_gmt":"2020-03-23T06:04:01","slug":"pharmacogenomics-technology-market-analysis-new-opportunities-explored-expansion-at-high-cagr-anticipated-by-2025-million-insights","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharmacogenomics-technology-market-analysis-new-opportunities-explored-expansion-at-high-cagr-anticipated-by-2025-million-insights_475435.html","title":{"rendered":"Pharmacogenomics Technology Market Analysis – New Opportunities Explored, Expansion at High CAGR Anticipated by 2025 | Million Insights"},"content":{"rendered":"
\"Pharmacogenomics<\/a><\/p>\n
\n
Million Insights – World’s Fastest Growing Market Research Database<\/div>\n<\/div>\n<\/div>\n
According to new report available with Million Insights, the global pharmacogenomics theranostics & companion diagnostics (CDx) industry report on is foretold to provide a robust support for market players to lay a solid foundation for their business growth. It includes a comprehensive evaluation of the market\u2019s growth status and market risk.<\/div>\n

Market Slingshot:<\/strong><\/span><\/p>\n

The scope of the global Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Market<\/strong><\/a> was appreciated by US$ 5.62 billion in 2016 and it is likely to reach US$ 18.3 billion during the forecast period. This could be attributed to growth in geriatric population, prevalence of chronic diseases like HIV, tuberculosis, and cancer, increase in awareness amongst the patients regarding personalized therapy, and adoption of pharmacogenomics by loads of healthcare professionals.<\/p>\n

The pharmacogenomics technology market is also likely to get bolstered technological advancements related to molecular diagnostics. At the same time, there is a dearth on the part of highly skilled and trained healthcare professionals in conducting pharmacogenomics diagnostics tests. Besides, emerging economies need to think twice before affirming pharmacogenomics tests as initial as well as operating costs are high. Governments herein do struggle with funding on this count.<\/p>\n

You Can Also Get Absolutely Free Sample Copy at: https:\/\/www.millioninsights.com\/industry-reports\/pharmacogenomics-technology-market\/request-sample<\/a><\/strong><\/p>\n

Market Segmentation:<\/strong><\/span><\/p>\n

The pharmacogenomics theranostics market is segmented by application, technology, end-user, and geography. By application, the segmentation goes like cardiovascular disease, pain management, psychiatry, infectious diseases, oncology, and neurological disease. By technology, the pharmacogenomics technology industry spans sequencing, polymerase chain reaction, mass spectrometry, microarray, and electrophoresis. By end-user, the pharmacogenomics companion diagnostics (CDx) market states research organizations & academic institutes and hospitals and clinics. By geography, it comprises North America, Asia Pacific, LATAM, Europe, and MEA.<\/p>\n

Regional Insights:<\/strong><\/span><\/p>\n

North America rules the roost; thanks to extensive investment in healthcare by the U.S. Europe comes in second due to Belgium and Denmark being on the top pedestal with respect to healthcare. Asia Pacific is expected to grow at the fastest pace owing to increase in awareness among the economies like India and China regarding healthcare. LATAM will also catch up due to presence of Brazil; followed by MEA. In fact, MEA would be more vigilant on this count; due to the figures released by WHO. It says that over 50% of the diseases mentioned above occur in sub-Saharan Africa.<\/p>\n

Players:<\/strong><\/span><\/p>\n

The players contributing to the pharmacogenomics technology market include OPKO Health, Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceutical Industries Ltd., Dynamic DNA Laboratories, Abbott Laboratories, F. Hoffmann-La Roche Ltd., One Ome LLC, Empire Genomics, LLC, and Illumina, Inc.<\/p>\n

Want To Access Full Research Report On Global Pharmacogenomics Technology Market? Click Here: https:\/\/www.millioninsights.com\/industry-reports\/pharmacogenomics-technology-market<\/a><\/strong><\/p>\n

Market Segment:<\/strong><\/span><\/p>\n

Therapeutic Area Outlook (Revenue, USD Million; 2014 – 2025)<\/strong>
    • Oncology
        • Lung Cancer
        • Breast Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Others
    • Neurological Disorders
    • Cardiovascular Disease
    • Immunological Disorders
    • Others<\/p>\n

Technology Outlook (Revenue, USD Million; 2014 – 2025)<\/strong>
    • PCR
    • In-situ Hybridization
    • Immunohistochemistry
    • Sequencing
    • Others<\/p>\n

Regional Outlook (Revenue, USD Million; 2014 – 2025)<\/strong>
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • China
        • Japan
    • Latin America
        • Brazil
    • Middle East & Africa
        • South Africa<\/p>\n

Browse reports of similar category available with Million Insights:<\/strong><\/span><\/p>\n

1. Cellular Health Screening Market – https:\/\/www.millioninsights.com\/industry-reports\/cellular-health-screening-market<\/a><\/strong><\/p>\n

2. Clinical Laboratory Services Market – https:\/\/www.millioninsights.com\/industry-reports\/clinical-laboratory-services-market<\/a><\/strong><\/p>\n

About Million Insights<\/strong>
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.<\/p>\n

For More Information: www.millioninsights.com<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Million Insights<\/a>
Contact Person:<\/strong> Ryan Manuel
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 91-20-65300184
Address:<\/strong>Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> https:\/\/www.millioninsights.com\/industry-reports\/pharmacogenomics-technology-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Million Insights – World’s Fastest Growing Market Research Database According to new report available with Million Insights, the global pharmacogenomics theranostics & companion diagnostics (CDx) industry report on is foretold to provide a robust support for market players to lay … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,410,406,411],"tags":[],"class_list":["post-475435","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Manufacturing-Industry","category-Pharmaceuticals-Biotech","category-Technology"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/475435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=475435"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/475435\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=475435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=475435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=475435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}